摘要
目的探讨血清CA125对预测肺癌转移的临床应用价值。方法应用化学发光免疫分析技术检测2197例肺癌患者血清肿瘤标志物CA125水平。结果2197例肺癌患者中，未发生转移的患者为1105人，CA125的中位数为55.23U／ml；发生转移的患者为1092人，CA125的中位数值为908.56U／ml。发生转移的患者血清CA125中位数显著高于未发生转移的肺癌患者（P〈0．01）。结论血清CA125水平对肺癌的转移有重要的提示意义。
Objective To evaluate Clinical value of serum CA125 in patients with Metastatic lung cancer. Methods Total 2197 patients with lung cancer were enrolled in the study, including 1092 cases with metastasis and 1105 cases without metastasis; serum CA125 revels were determined by chemiluminescence immunoassay. Results The median value of serum CA125 in metastatic cases were significantly higher than that in non-metastatic cases （908.56U/ml vs 55.23U/m, P 〈0.01 ）. Conclution The detection of serum CA125 is of value in prediction of metastasis in lung cancer.
出处
《浙江医学》
CAS
2009年第5期599-601,共3页
Zhejiang Medical Journal
